<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Br J Radiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Br J Radiol</journal-id>
<journal-id journal-id-type="publisher-id">bjr</journal-id>
<journal-title-group>
<journal-title>The British Journal of Radiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0007-1285</issn>
<issn pub-type="epub">1748-880X</issn>
<publisher>
<publisher-name>The British Institute of Radiology.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31124710</article-id>
<article-id pub-id-type="pmc">6732925</article-id>
<article-id pub-id-type="publisher-manuscript">BJR-D-18-00944</article-id>
<article-id pub-id-type="doi">10.1259/bjr.20180944</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Advances in neurodegenerative and psychiatric imaging special feature: Review article</subject>
</subj-group>
<subj-group subj-group-type="topic">
<compound-subject>
<compound-subject-part content-type="code">bjr</compound-subject-part>
<compound-subject-part content-type="label">BJR</compound-subject-part>
</compound-subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Revisiting the excitation/inhibition imbalance hypothesis of ASD through a clinical lens</article-title>
<alt-title alt-title-type="right-running-head">“E/I imbalance in ASD: viewed through a clinical lens”</alt-title>
<alt-title alt-title-type="left-running-head">Port <italic>et al</italic></alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Port</surname>
<given-names>Russell G</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1 aff2">1,2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oberman</surname>
<given-names>Lindsay M</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<email>lindsay.oberman.ctr@usuhs.edu</email>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7320-4870</contrib-id>
<name>
<surname>Roberts</surname>
<given-names>Timothy PL</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1">1</xref>
<email>robertstim@email.chop.edu</email>
</contrib>
<aff id="aff1">
<label>1</label>
<institution content-type="org-division">Department of Radiology, Lurie Family Foundations MEG Imaging Center, Children’s Hospital of Philadelphia</institution>, <country>Pennsylvania</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution content-type="org-division">Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, <country>Pennsylvania</country>
</aff>
<aff id="aff3">
<label>3</label>
<institution content-type="org-division">Center for Neuroscience and Regenerative Medicine, Henry M. Jackson Foundation for the Advancement of Military Medicine</institution>, <addr-line>Rockville</addr-line>, <country>Maryland</country>
</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address correspondence to: Prof Timothy PL Roberts. E-mail: <email xlink:href="mailto:robertstim@email.chop.edu">robertstim@email.chop.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>92</volume>
<issue>1101</issue>
<elocation-id>20180944</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>5</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 The Authors. Published by the British Institute of Radiology</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>The Authors</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="bjr.20180944.pdf"></self-uri>
<abstract>
<p>Autism spectrum disorder (ASD) currently affects 1 in 59 children, although the aetiology of this disorder remains unknown. Faced with multiple seemingly disparate and noncontiguous neurobiological alterations, Rubenstein and Merzenich hypothesized that imbalances between excitatory and inhibitory neurosignaling (E/I imbalance) underlie ASD. Since this initial statement, there has been a major focus examining this exact topic spanning both clinical and preclinical realms.</p>
<p>The purpose of this article is to review the <italic>clinical</italic> neuroimaging literature surrounding E/I imbalance as an aetiology of ASD. Evidence for E/I imbalance is presented from several complementary clinical techniques including magnetic resonance spectroscopy, magnetoencephalography and transcranial magnetic stimulation. Additionally, two GABAergic potential interventions for ASD, which explicitly attempt to remediate E/I imbalance, are reviewed.</p>
<p>The current literature suggests E/I imbalance as a useful framework for discussing the neurobiological etiology of ASD in at least a subset of affected individuals. While not constituting a completely unifying aetiology, E/I imbalance may be relevant as one of several underlying neuropathophysiologies that differentially affect individuals with ASD. Such statements do not diminish the value of the E/I imbalance concept—instead they suggest a possible role for the characterization of E/I imbalance, as well as other underlying neuropathophysiologies, in the biologically-based subtyping of individuals with ASD for potential applications including clinical trial enrichment as well as treatment triage.</p>
</abstract>
<counts>
<fig-count count="4"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="148"></ref-count>
<page-count count="0"></page-count>
<word-count count="13482"></word-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>